Literature DB >> 26074620

Heart failure and comorbidities: renal failure, diabetes, atrial fibrillation, and inflammation.

Thomas F Lüscher1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26074620     DOI： 10.1093/eurheartj/ehv156

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  The economic case for US hospitals to revise their approach to heart failure readmission reduction.

Authors:  Armineh Zohrabian; Julie M Kapp; Eduardo J Simoes
Journal:  Ann Transl Med       Date:  2018-08

2.  DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety.

Authors:  Francesco Paneni
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

3.  Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Paul M McKie; Shannon M Dunlay; Susanna R Stevens; G Michael Felker; Barry A Borlaug; Horng H Chen; Russell P Tracy; Eugene Braunwald; Margaret M Redfield
Journal:  J Am Heart Assoc       Date:  2017-02-18       Impact factor: 5.501

4.  Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data.

Authors:  Agnė Šatrauskienė; Rokas Navickas; Aleksandras Laucevičius; Heinrich J Huber
Journal:  BMC Cardiovasc Disord       Date:  2017-06-30       Impact factor: 2.298

5.  GAS5 regulates diabetic cardiomyopathy via miR‑221‑3p/p27 axis‑associated autophagy.

Authors:  Dezhi Chen; Min Zhang
Journal:  Mol Med Rep       Date:  2020-12-14       Impact factor: 2.952

6.  Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure.

Authors:  Imad Kassem; Steven Sanche; Jun Li; Guillaume Bonnefois; Marie-Pierre Dubé; Jean-Lucien Rouleau; Jean-Claude Tardif; Michel White; Jacques Turgeon; Fahima Nekka; Simon de Denus
Journal:  Clin Transl Sci       Date:  2020-08-28       Impact factor: 4.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.